These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2524855)

  • 21. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Brain Res Bull; 1985 Oct; 15(4):377-84. PubMed ID: 2933126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsensitivity of serotonin and substance P receptors involved in nociception after repeated administration of a serotonin receptor agonist.
    Eide PK; Hole K
    J Neural Transm; 1989; 77(1):1-10. PubMed ID: 2545812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.
    Goodwin GM; De Souza RJ; Green AR
    Neuropharmacology; 1985 Dec; 24(12):1187-94. PubMed ID: 2869435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.
    Shepherd JK; Rodgers RJ
    Psychopharmacology (Berl); 1990; 101(3):408-13. PubMed ID: 2141947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ; Goodwin GM; Green AR; Heal DJ
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacological analysis of the eating response induced by 8-OH-DPAT injected into the dorsal raphé nucleus reveals the involvement of a dopaminergic mechanism.
    Fletcher PJ; Davies M
    Psychopharmacology (Berl); 1990; 100(2):188-94. PubMed ID: 2137632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased population spike amplitude in the dentate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino)tetralin.
    Klancnik JM; Baimbridge KG; Phillips AG
    Brain Res; 1989 Dec; 505(1):145-8. PubMed ID: 2532947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement by the putative 5-HT receptor agonist 8-OH-2-(di-n-propylamino)tetralin of the acoustic startle response in the rat.
    Svensson L; Ahlenius S
    Psychopharmacology (Berl); 1983; 79(2-3):104-7. PubMed ID: 6221350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feeding responses to a high dose of 8-OH-DPAT in young and adult rats: influence of food texture.
    Chaouloff F; Serrurrier B; Mérino D; Laude D; Elghozi JL
    Eur J Pharmacol; 1988 Jul; 151(2):267-73. PubMed ID: 2458945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
    Yu H; Liu Y; Hacksell U; Lewander T
    J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
    Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.